SCHEMBL6800754

SCHEMBL6800754

C#CCOc1ccc(CCNC(=O)/C(=C/OC(F)F)c2ccc3ccccc3c2)cc1OC

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
RXFP1 Q9HBX9 1/20 0.45
ALDH1A1 P00352 6/20 0.45
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
KMT2A Q03164 2/20 0.42
PKM P14618 1/20 0.42
PLAAT3 P53816 1/20 0.41
PLAAT5 Q96KN8 1/20 0.41
PLAAT2 Q9NWW9 1/20 0.41
PLAAT4 Q9UL19 1/20 0.41
POLB P06746 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
OPRM1 P35372 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
NAMPT P43490 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6800757 1.00 MAPT (0.45) MAPTRXFP1ALDH1A1HPGDSMN1; SMN2
SCHEMBL6803899 0.92 ALDH1A1 (0.49) MAPTALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL6803902 0.92 ALDH1A1 (0.49) MAPTALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL6799222 0.91 MAPT (0.48) MAPTALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL6799219 0.91 MAPT (0.48) MAPTALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL6800751 0.91 MAPT (0.54) MAPTRXFP1ALDH1A1HPGDSMN1; SMN2
SCHEMBL6800756 0.91 MAPT (0.54) MAPTRXFP1ALDH1A1HPGDSMN1; SMN2
SCHEMBL6800578 0.89 ALDH1A1 (0.51) MAPTALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL6795575 0.89 KMT2A (0.46) MAPTALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL6800575 0.89 ALDH1A1 (0.51) MAPTALDH1A1HPGDSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762321-B2 SUCH AS N-(2-(3,4-DIMETHOXYPHENYL)ETHYL)-3-DIFLUOROMETHOXY-2-(4 -METHYLPHENYL)ACRYLAMIDE; FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-13 US disclosed
US-20030195354-A1 Amide compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-16 US disclosed
EP-1295868-A1 AMIDE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195354-A1 Amide compounds and use thereof CBR1, CBR3, NAT1 MAPT 3676/4885RXFP1 681/4885ALDH1A1 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.